Insider trade

Medtronic (MDT): CFO had shares withheld for tax 2,976 shares

Thierry Pieton, CFO at Medtronic, reported a tax withholding of 2,976 shares.

2,976
Shares · @ $96.71
Traded
Mar 3, 2026
Filed
Mar 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 18, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  2. Feb 5, 2026Layoff notice · 18000 Devonshire Street Northridge CA 91325Layoff notice filed in CA: 81 employees
  3. Feb 17, 2026Company filing · Form 8-K · ResultsReported its results
  4. Feb 19, 2026Insider · 1 personInsiders: 5 sales (~$5.1M)

What came next

  1. Mar 20, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
  2. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  3. Apr 28, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  4. May 15, 2026CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  5. May 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 18, 2026, Medtronic plc (“Medtronic” or the “Company”) announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.”
  6. Jun 3, 2026Company filing · Form 8-K · ResultsReported its results
  7. Jun 8, 2026Insider · 1 personInsiders: 2 sales (~$337K)
  8. Jun 16, 2026FDARecall: MiniMed Go App, Model: MMT-8600 (iOS), MMT-8601 (Android)
  9. Jun 17, 2026FDARecall: Ventriculostomy Kit, REF: 46154
  10. Jun 24, 2026FDAFDA device clearance: Concerto Versa™ Detachable Coil
  11. Jun 24, 2026FDARecall: EOPA Elongated One-Piece Arterial Cannula DIL TIP 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 77722
  12. Jun 24, 2026FDARecall: EOPA 3D Arterial Cannula 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 78322
  13. Jun 24, 2026FDARecall: EOPA 3D Arterial Cannula DIL TIP 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 78222
  14. Jun 24, 2026FDARecall: EOPA Elongated One-Piece Arterial Cannula BLUNT 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 77422
  15. Jun 24, 2026FDARecall: EOPA Elongated One-Piece Arterial Cannula DIL TIP 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 77622
  16. Jun 24, 2026FDARecall: EOPA Elongated One-Piece Arterial Cannula BLUNT 22FR, intended for use with cardiopulmonary bypass as an arterial return cannula, Model Number 77522
  17. Jun 24, 2026FDARecall: V-Loc 180 Absorbable Wound Closure Device BOX BEDSIDE STAPLING IS KING BOX06614V4 BOX BY PASS FINAL BOX07405V1 BOX BYPASS CARDON BOX01056V2 BOX BYPASS DR LAGAE…
  18. Jun 24, 2026FDARecall: Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX
  19. Jun 24, 2026FDARecall: V-Loc 90 Absorbable Wound Closure Device VLOC 90 0 VL 22 GS-21 VLOCM0336 VLOC 90 0 VL 22 GS-25 VLOCM0436 VLOCM0436 VLOCM0003 V-LOC* 90 4-0 CLR 15CM P12X12 VLOC…
  20. Jun 24, 2026FDARecall: Surgipro SP-623 SURGIPRO* 2-0 BLU 75CM SC2 X36 SP-623
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

How this filing works

Explore the data

Common questions

Which Medtronic (MDT) insider traded, and how much?

Thierry Pieton, CFO at Medtronic, reported a tax withholding of 2,976 shares. At $96.71.

When did it happen, and when was it made public?

Traded: Mar 3, 2026. Filed: Mar 6, 2026. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Medtronic recently?

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MDT page.

Does this mean MDT stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data